Corrigendum to "MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system" [Pharmacology & Therapeutics 213 (2020) 107577].

Pharmacol Ther

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, GA, USA. Electronic address:

Published: September 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2021.107822DOI Listing

Publication Analysis

Top Keywords

corrigendum "mertk
4
"mertk cancer
4
cancer therapy
4
therapy targeting
4
targeting receptor
4
receptor tyrosine
4
tyrosine kinase
4
kinase tumor
4
tumor cells
4
cells immune
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!